Atlas Trials

Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder

Clinical trial NCT01694667 · COMPLETED

Trial details

NCT number
NCT01694667
Sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Autism Spectrum DisordersHyperactivity
Start date
2012-09-01
Primary completion
2012-12-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.